Will continue working with colleagues to get the Combating Illicit Xylazine Act signed into law.

Deborah K. Ross · North Carolina · Democratic

policy impact 0.62 specificity 0.88 extraction confidence 93%

Commitment kind: action. Promised action: Continue working with colleagues to get the Combating Illicit Xylazine Act signed into law.. Promised outcome: The Combating Illicit Xylazine Act is signed into law.. Deadline: unknown; not assumed expired. U.S. Representative for North Carolina's 2nd District discussing the Combating Illicit Xylazine Act after House passage in the 119th Congress.

Contest this claim

Occurrences

“Fentanyl overdoses continue to take far too many lives, in no small part due to the widespread availability of deadly substances like xylazine,” said Rep. Ross. “This bipartisan bill will save lives by restricting access to this dangerous substance and giving law enforcement the tools they need to crack down on traffickers, while protecting legitimate uses of xylazine by veterinarians, farmers, and ranchers. I am grateful for the House of Representatives’ bipartisan commitment to passing this legislation, and I will continue working with my colleagues to get this bill signed into law.”

In a House office press release after unanimous House passage of the Combating Illicit Xylazine Act, Ross committed to keep working with colleagues to get the bill signed into law.

Rep. Ross’ Combating Illicit Xylazine Act Passes House Unanimously | Press Releases | Representative Deborah Ross
primary · press_release · model gpt-5.5

Evidence

unverified · Source version 57859 · locator unknown

09/15/2026 19:24:44 ... H.R. 1266 | Motion to reconsider laid on the table Agreed to without objection. ... On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official House floor record shows H.R. 1266, the Combating Illicit Xylazine Act, passed the House by voice vote on September 15, 2026, but this was House passage only, not enactment.

unresolved same_term A for effort

Office of the Clerk, U.S. House of Representatives - Bills: September 15th, 2026
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

verified · Source version 57856 · locator 1750

The legislation now heads to the Senate for consideration.

Fetched verbatim passage. AI summary (separate from source): Rep. Ross's official release confirms recent progress and also confirms the bill still required Senate action as of September 16, 2026, so the signed-into-law commitment remained unresolved.

unresolved same_term A for effort

Rep. Ross’ Combating Illicit Xylazine Act Passes House Unanimously | Press Releases | Representative Deborah Ross
primary · model gpt-5.5 · confidence 97%

Contest this evidence item

Assessments

Public state: pending As of 2026-09-17 · verified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

The verified commitment was to keep working with colleagues to get the Combating Illicit Xylazine Act signed into law. The only verified outcome evidence says the legislation still headed to the Senate for consideration, so enactment had not been shown as of 2026-09-17. With no documented deadline expired, this remains unresolved rather than never. The record supports effort/progress but not delivery or attributable partial enactment.

provider codex_cli · model gpt-5.5 · confidence 97%